The DOI matches its Crossref record; 254 of the 254 references it cites were found in a registry or an index.
Thyroid hormones and cardiovascular disease
Open accessAbstract
Myocardial and vascular endothelial tissues have receptors for thyroid hormones and are sensitive to changes in the concentrations of circulating thyroid hormones. The importance of thyroid hormones in maintaining cardiovascular homeostasis can be deduced from clinical and experimental data showing that even subtle changes in thyroid hormone concentrations - such as those observed in subclinical hypothyroidism or hyperthyroidism, and low triiodothyronine syndrome - adversely influence the cardiovascular system. Some potential mechanisms linking the two conditions are dyslipidaemia, endothelial dysfunction, blood pressure changes, and direct effects of thyroid hormones on the myocardium. Several interventional trials showed that treatment of subclinical thyroid diseases improves cardiovascular risk factors, which implies potential benefits for reducing cardiovascular events. Over the past 2 decades, accumulating evidence supports the association between abnormal thyroid function at the time of an acute myocardial infarction (MI) and subsequent adverse cardiovascular outcomes. Furthermore, experimental studies showed that thyroid hormones can have an important therapeutic role in reducing infarct size and improving myocardial function after acute MI. In this Review, we summarize the literature on thyroid function in cardiovascular diseases, both as a risk factor as well as in the setting of cardiovascular diseases such as heart failure or acute MI, and outline the effect of thyroid hormone replacement therapy for reducing the risk of cardiovascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the context of HF, THs have a cardioprotective role through multifaceted direct or indirect actions at the level of the myocytes, the interstitium, and the vasculature (Figure 2) (6).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [6]
In the citing paper
“Although a reduction in oxygen consumption by lowering TH levels during acute ischemia could be considered beneficial, the net effect of lower TH levels in the heart may still be detrimental because of its important role in postischemic LV remodeling, maintaining CV function and mitochondrial integrity (6).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [6]
In the citing paper
“Patients with severe hyperthyroidism may have coronary vasospasm leading to chest pain at rest or myocardial ischemia(6,70,71,79).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [6]
In the citing paper
“excess increases cardiac output by affecting stroke volume and heart rate(6,71).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [6]
Citations
Cites
Items 201–254 of 254
Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism
Aghini-Lombardi, F., Vitantonio, D. B., Enrica, T., Cori, A. D., Monzani, F., Lucia, A., Palagi, C., Caraccio, N., Grazia, D. D. M., Carmela, N., et al. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02174 · Cited by 61
Thyroid hormone and myocardial mitochondrial biogenesis
Marı́n-Garcı́a, J. (2009) · Vascular Pharmacology · doi:10.1016/j.vph.2009.10.008 · Cited by 60
A low fT3 level as a prognostic marker in patients with acute myocardial infarctions
Zhang, B., Peng, W., Wang, C., Li, W., & Xu, Y. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.7902 · Cited by 59
Chen, Y., Weltman, N. Y., Li, X., Youmans, S. J., Krause, D., & Gerdes, A. M. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-40 · Cited by 58
Cerillo, A. G., Storti, S., Kallushi, E., Haxhiademi, D., Miceli, A., Murzi, M., Berti, S. L., Glauber, M., Clerico, A., & Iervasi, G. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.01.049 · Cited by 57
Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats
Husseini, A. A., Bagnato, G., Farkas, L., Gomez‐Arroyo, J. G., Farkas, D., Mizuno, S., Kraskauskas, D., Abbate, A., Tassel, B. W. V., Voelkel, N. F., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00196511 · Cited by 57
Passino, C., Pingitore, A., Landi, P., Fontana, M., Zyw, L., Clerico, A., Emdin, M., & Iervasi, G. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.08.008 · Cited by 54
The association between subclinical hyperthyroidism and blood pressure in a population-based study
Völzke, H., Alte, D., Dörr, M., Wallaschofski, H., John, U., Felix, S. B., & Rettig, R. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000244942.57417.8e · Cited by 54
Dörr, M., Empen, K., Robinson, D. M., Wallaschofski, H., Felix, S. B., & Völzke, H. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0140 · Cited by 54
Kimura, T., Kanda, T., Kotajima, N., Kuwabara, A., FUKUMURA, Y., & Kobayashi, I. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430179 · Cited by 52
Clinical review: thyroid hormone replacement in children after cardiac surgery--is it worth a try?
Haas, N. A., Camphausen, C. K., & Kececioglu, D. (2006) · Critical Care · doi:10.1186/cc4924 · Cited by 52
Holt, E., Sjaastad, I., Lunde, P., Christensen, G., & Sejersted, O. M. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0900 · Cited by 51
Impact of Triiodothyronine on the Survival of High-Risk Patients Undergoing Open Heart Surgery
Novitzky, D., Fontanet, H. L., Snyder, M., Coblio, N. A., Smith, D., & Parsonnet, V. (2008) · Cardiology · doi:10.1159/000177147 · Cited by 51
Cardioprotection and thyroid hormones
Pingitore, A., Nicolini, G., Kusmic, C., Iervasi, G., Grigolini, P., & Forini, F. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9545-8 · Cited by 51
Özcan, K. S., Osmonov, D., Toprak, E., Güngör, B., Tatlısu, A., Ekmekçi, A., Kaya, A., Tayyareci, G., & Erdinler, İ. (2014) · Cardiology Journal · doi:10.5603/cj.a2013.0108 · Cited by 50
Chuang, C.-P., Jong, Y.-S., Wu, C.-Y., & Lo, H. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.11.039 · Cited by 48
Pingitore, A., Chen, Y., Gerdes, A. M., & Iervasi, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.573501 · Cited by 47
Nagasaki, T., Inaba, M., Yamada, S., Shirakawa, K., Nagata, Y., Kumeda, Y., Hiura, Y., Tahara, H., Ishimura, E., & Nishizawà, Y. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0742 · Cited by 47
Rajagopalan, V., Zhang, Y., Ojamaa, K., Chen, Y., Pingitore, A., Pol, C. J., Saunders, D., Balasubramanian, K., Towner, R. A., & Gerdes, A. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151413 · Cited by 47
The coronary drug project--findings with regard to estrogen, dextrothyroxine, clofibrate and niacin.
Stamler, J. (1977) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4613-4220-5_6 · Cited by 46
Holmager, P., Schmidt, U., Mark, P., Andersen, U. B., Domínguez, H., Raymond, I. E., Zerahn, B., Nygaard, B., Kistorp, C., & Faber, J. O. (2014) · Clinical Endocrinology · doi:10.1111/cen.12648 · Cited by 46
Silva-Tinoco, R., Castillo‐Martínez, L., Orea‐Tejeda, A., Orozco-Gutíerrez, J. J., Vázquez-Díaz, O., Montaño-Hernández, P., Flores-Rebollar, A., & Reza‐Albarrán, A. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.01.012 · Cited by 46
Thyroid Hormone and Cardiac Disease: From Basic Concepts to Clinical Application
Mourouzis, I. S., Forini, F., Pantos, C. I., & Iervasi, G. (2011) · Journal of Thyroid Research · doi:10.4061/2011/958626 · Cited by 44
Evaluation of epicardial fat tissue thickness in patients with H ashimoto thyroiditis
Aşık, M., Şahin, S., Özkul, F., Anaforoğlu, İ., Ayhan, S., Karagol, S., Güneş, F., & Algün, E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12176 · Cited by 39
The Thyroid Hormone Receptor-β Agonist GC-1 Induces Cell Proliferation in Rat Liver and Pancreas
Columbano, A., Pibiri, M., Deidda, M., Cossu, C., Scanlan, T. S., Chiellini, G., Muntoni, S., & Ledda‐Columbano, G. M. (2006) · Endocrinology · doi:10.1210/en.2005-1561 · Cited by 39
Expression of vascular adhesion molecules on human endothelia in autoimmune thyroid disorders
Marazuela, M., Sánchez‐Madrid, F., Acevedo, A., Larrañaga, E., & Landázuri, M. O. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03785.x · Cited by 37
Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure
Lubrano, V., Pingitore, A., Carpi, A., & Iervasi, G. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.09.001 · Cited by 35
de Castro, A. L., Fernandes, R. O., Ortiz, V. D., Carraro, C. C., Bonetto, J. H. P., Fernandes, T. R. G., Conzatti, A., Siqueira, R., Tavares, Â. M. V., Schenkel, P. C., et al. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1204-3 · Cited by 34
Dörr, M., Ittermann, T., Aumann, N., Obst, A., Reffelmann, T., Nauck, M., Wallaschofski, H., Felix, S. B., & Völzke, H. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03882.x · Cited by 33
Kaasik, A. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00069-2 · Cited by 32
Madathil, A., Hollingsworth, K. G., Blamire, A. M., Razvi, S., Newton, J. L., Taylor, R., & Weaver, J. U. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2942 · Cited by 32
The discovery of thyroid replacement therapy. Part 3: A complete transformation
Slater, S. D. (2011) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2010.10k052 · Cited by 31
Virtanen, V. K., Saha, H. H. T., Groundstroem, K. W. E., Salmi, J., & Pasternack, A. I. (2001) · Cardiology · doi:10.1159/000047390 · Cited by 29
Suk, J. H., Cho, K. I., Lee, S. H., Lee, H. G., Kim, S. M., Kim, T. I., Kim, M.-K., & Shong, Y. K. (2011) · PubMed · doi:10.3275/7573 · Cited by 27
Prevalence of Subclinical Hypothyroidism among Patients with Acute Myocardial Infarction
Okuyan, E., Uslu, A., Asim, E., Gulcin, H. E., Ayça, B., Avşar, M., Sezai, Y. S., Biter, H. İ., & Hakan, D. M. (2011) · ISRN Endocrinology · doi:10.5402/2011/810251 · Cited by 25
Viswanathan, G., Balasubramaniam, K., Hardy, R., Marshall, S., Zaman, A., & Razvi, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3062 · Cited by 25
Correlation of circulating interleukin-10 with thyroid hormone in acute myocardial infarction.
Kimur, T., Kotajima, N., Kanda, T., KUWABARA, A., FUKUMURA, Y., & Kobayashi, I. (2001) · PubMed · Cited by 24
James, S. R., Ranasinghe, A. M., Venkateswaran, R., McCabe, C. J., Franklyn, J. A., & Bonser, R. S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1659 · Cited by 23
Suárez, J., Wang, H., Scott, B. T., Ling, H., Makino, A., Swanson, E., Brown, J. H., Suárez, J., Feinstein, S., Díaz-Juárez, J. A., et al. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00449.2013 · Cited by 23
Vascular degeneration in hypothyroidism.
KOUNTZ, W. B. (1950) · PubMed · Cited by 23
PROPHYLAXIS OF ISCHÆMIC HEART-DISEASE BY THYROID THERAPY
Barnes, B. O. (1959) · The Lancet · doi:10.1016/s0140-6736(59)90561-6 · Cited by 22
Diagnosis and treatment of primary hypothyroidism
Allahabadia, A., Razvi, S., Abraham, P., & Franklyn, J. (2009) · BMJ · doi:10.1136/bmj.b725 · Cited by 21
Changes in cardiac function at rest before and after treatment in primary hypothyroidism
Tielens, E. T., Pillay, M., Storm, C. J., & Berghout, A. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00750-x · Cited by 21
Li, L., Guo, C., Yang, J., Jia, E., Zhu, T., Wang, L., Cao, K., Ma, W., & Yang, Z. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.118 · Cited by 20
Nagasaki, T., Inaba, M., Yamada, S., Kumeda, Y., Hiura, Y., & Nishizawà, Y. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.04.004 · Cited by 20
Lim, A. S. A. L., Paz-Pacheco, E. T., Reyes, M. S. P., & Punzalan, F. E. R. (2011) · BMJ Case Reports · doi:10.1136/bcr.04.2011.4117 · Cited by 20
Type 3 Deiodinase in Hypoxia: To Cool or to Kill?
Diano, S., & Horváth, T. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.008 · Cited by 19
Thyroid disease and vascular risk
Jabbar, A., & Razvi, S. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-6-s29 · Cited by 19
Yazıcı, D., Özben, B., Toprak, A. C., Yavuz, D. G., Aydın, H., Tarçın, Ö., Deyneli, O., & Akalın, S. (2014) · Endocrine · doi:10.1007/s12020-014-0372-1 · Cited by 18
Pathophysiology of Myocardial Injury and Remodeling: Implications for Molecular Imaging
Dixon, J. A., & Spinale, F. G. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.068213 · Cited by 15
On the Genesis of Atherosclerosis*
Barnes, B. O. (1973) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1973.tb01239.x · Cited by 14
CORONARY-ARTERY DISEASE IN MYX$OElig;DEMA
Vanhaelst, L. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90599-5 · Cited by 13
[Subclinical hyperthyroidism and atrial fibrillation].
Auer, J., & Eber, B. (2003) · PubMed · Cited by 8
MYXODEMA. FOUR CASES, WITH TWO AUTOPSIES
Hun, H., & Prudden, T. M. (1888) · The American Journal of the Medical Sciences · doi:10.1097/00000441-188807000-00001 · Cited by 6
Flagged first, then by citations
Research works printed but not linked: 1
- Kocher, T. Ueber Kropfexstirpation und ihre Folgen. Arch. Klin. Chir. 29, 254–337 (in German) (1883).
Cited by
Sorted by citations
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,072
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
Thyroid Hormones and Cardiovascular Function and Diseases
Razvi, S., Jabbar, A., Pingitore, A., Danzi, S., Biondi, B., Klein, I., Peeters, R., Zaman, A., & Iervasi, G. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.045 · Cited by 515
Metadata
- Authors
- Jabbar, A., Pingitore, A., Pearce, S. H. S., Zaman, A., Iervasi, G., & Razvi, S.
- Affiliations
- Freeman Hospital (GB)
- Istituto di Fisiologia Clinica (IT)
- Royal Victoria Infirmary (GB)
- Gateshead Health NHS Foundation Trust (GB)
- Corresponding author
- Razvi, Salman
- Venue
- Nature Reviews Cardiology
- Published
- 2016-11-04
- Volume
- 14
- Issue
- 1
- Pages
- 39-55
- ISSN
- 1759-5002 (ISSN-L)
- 1759-5010
- OpenAlex
- W2548036931
- Cited by
- 729
- References
- 253
- Citations by year
- 2026: 65 · 2025: 78 · 2024: 89 · 2023: 95 · 2022: 107 · 2021: 87 · 2020: 88 · 2019: 47 · 2018: 42 · 2017: 25
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute for Health and Care Research (PB-PG-0610-22139, CDF-2012-05-231)
- Medical Research Council (G0500783)
- NIHR Academy
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- thyroid hormones, cardiovascular disease, heart failure, acute myocardial infarction, subclinical hypothyroidism, hyperthyroidism, low triiodothyronine syndrome, thyroid hormone receptor, endothelial dysfunction, dyslipidemia, blood pressure, thyroid hormone replacement, cardiovascular risk factors, infarct size
- MeSH terms
- Cardiovascular Diseases, Cardiovascular System, Humans, Hyperthyroidism, Hypothyroidism, Thyroid Hormones, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
